Follow
Vilja Pietiäinen
Vilja Pietiäinen
Adj. Prof, PhD, University of Helsinki
Verified email at helsinki.fi
Title
Cited by
Cited by
Year
Screening out irrelevant cell-based models of disease
P Horvath, N Aulner, M Bickle, AM Davies, ED Nery, D Ebner, ...
Nature reviews Drug discovery 15 (11), 751-769, 2016
5122016
The impact of low-frequency and rare variants on lipid levels
I Surakka, M Horikoshi, R Mägi, AP Sarin, A Mahajan, V Lagou, L Marullo, ...
Nature genetics 47 (6), 589-597, 2015
3572015
Internalization of echovirus 1 in caveolae
V Marjomäki, V Pietiäinen, H Matilainen, P Upla, J Ivaska, L Nissinen, ...
Journal of virology 76 (4), 1856-1865, 2002
2972002
Echovirus 1 endocytosis into caveosomes requires lipid rafts, dynamin II, and signaling events
V Pietiäinen, V Marjomäki, P Upla, L Pelkmans, A Helenius, T Hyypiä
Molecular biology of the cell 15 (11), 4911-4925, 2004
2162004
Association of tamoxifen resistance and lipid reprogramming in breast cancer
S Hultsch, M Kankainen, L Paavolainen, RM Kovanen, E Ikonen, ...
BMC cancer 18, 1-14, 2018
1512018
Structural and functional analysis of integrin α2I domain interaction with echovirus 1
L Xing, M Huhtala, V Pietiäinen, J Käpylä, K Vuorinen, V Marjomäki, ...
Journal of biological chemistry 279 (12), 11632-11638, 2004
952004
Accurate morphology preserving segmentation of overlapping cells based on active contours
C Molnar, IH Jermyn, Z Kato, V Rahkama, P Östling, P Mikkonen, ...
Scientific reports 6 (1), 32412, 2016
852016
NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation
V Pietiäinen, B Vassilev, T Blom, W Wang, J Nelson, R Bittman, N Bäck, ...
Journal of cell science 126 (17), 3961-3971, 2013
852013
Advanced cell classifier: user-friendly machine-learning-based software for discovering phenotypes in high-content imaging data
F Piccinini, T Balassa, A Szkalisity, C Molnar, L Paavolainen, K Kujala, ...
Cell systems 4 (6), 651-655. e5, 2017
802017
Viral entry, lipid rafts and caveosomes
VM Pietiäinen, V Marjomäki, J Heino, T Hyypiä
Annals of medicine 37 (6), 394-403, 2005
702005
SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
X Liu, S Huuskonen, T Laitinen, T Redchuk, M Bogacheva, K Salokas, ...
Molecular Systems Biology 17 (11), e10396, 2021
582021
Cholesterol substitution increases the structural heterogeneity of caveolae
M Jansen, VM Pietiaïnen, H Pölönen, L Rasilainen, M Koivusalo, ...
Journal of biological chemistry 283 (21), 14610-14618, 2008
532008
Rab8 regulates ABCA1 cell surface expression and facilitates cholesterol efflux in primary human macrophages
MD Linder, MI Mäyränpää, J Peränen, TE Pietilä, ...
Arteriosclerosis, thrombosis, and vascular biology 29 (6), 883-888, 2009
502009
Effects of echovirus 1 infection on cellular gene expression
V Pietiäinen, P Huttunen, T Hyypiä
Virology 276 (2), 243-250, 2000
272000
Loss of DIAPH1 causes SCBMS, combined immunodeficiency, and mitochondrial dysfunction
M Kaustio, N Nayebzadeh, R Hinttala, T Tapiainen, P Åström, K Mamia, ...
Journal of Allergy and Clinical Immunology 148 (2), 599-611, 2021
232021
SpheroidPicker for automated 3D cell culture manipulation using deep learning
I Grexa, A Diosdi, M Harmati, A Kriston, N Moshkov, K Buzas, V Pietiäinen, ...
Scientific Reports 11 (1), 14813, 2021
19*2021
PeptiCHIP: a microfluidic platform for tumor antigen landscape identification
S Feola, M Haapala, K Peltonen, C Capasso, B Martins, G Antignani, ...
ACS nano 15 (10), 15992-16010, 2021
182021
The high throughput biomedicine unit at the institute for molecular medicine Finland: high throughput screening meets precision medicine
V Pietiainen, J Saarela, C von Schantz, L Turunen, P Ostling, ...
Combinatorial chemistry & high throughput screening 17 (4), 377-386, 2014
162014
iTReX: Interactive exploration of mono-and combination therapy dose response profiling data
D ElHarouni, Y Berker, H Peterziel, A Gopisetty, L Turunen, S Kreth, ...
Pharmacological research 175, 105996, 2022
132022
Drug response profiles in patient-derived cancer cells across histological subtypes of ovarian cancer: real-time therapy tailoring for a patient with low-grade serous carcinoma
A Murumägi, D Ungureanu, S Khan, M Arjama, K Välimäki, A Ianevski, ...
British Journal of Cancer 128 (4), 678-690, 2023
92023
The system can't perform the operation now. Try again later.
Articles 1–20